Table 5.
Drugs used in treatment of patent ductus arteriosus and their doses
Drug | Dose (mg/kg) | Route of administration | Rate of closure of PDA (%) | Adverse effects | Reopening (%) |
---|---|---|---|---|---|
Indomethacin | <48 hours | IV At least 30 min | 70-80 | Oliguria, reduction in creatinine clearance, electrolyte imbalance, bleeding in GIS, NEC, perforation | 20-35 |
1st dose: 0.2 mg/ kg 12 hours later 2nd dose: 0.1 mg/kg 24 hours later 3rd dose: 0.1 mg/kg | |||||
>48 hours | |||||
0.2 mg/kg with 12-24-hour intervals | |||||
Ibuprofen | Loading: 10 mg/kg with 24-hour intervals | IV or oral | 70-80 | Oliguria, reduction in creatinine clearance, | 30 |
5 mg/kg, 2 successive doses | hyperbilirubinemia, bleeding | ||||
Paracetamol | 15 mg/kg every 6 hours, po | Oral or IV 2-7 days | 90- 100 | Increase in liver enzymes | 30 |
GIS: gastrointestinal system, PDA: patent ductus arteriosus, NEC: necrotizing enterocolitis